welcome
ScienceDaily

ScienceDaily

Science

Science

Scientists identify a new cancer immunotherapy target: Dysfunctional B cells

ScienceDaily
Summary
Nutrition label

80% Informative

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood.

The finding gives oncologists a new target for developing immunotherapies: double negative memory B cells.

B cells are white blood cells, produced in the bone marrow, that neutralize pathogens.

This research was supported by the National Cancer Institute T 32 Cancer Immunology Training Program ( 2T32CA082084-16A1 ), UPMC Hillman Cancer Center Support Grant (P30CA047904), National Institute of Dental and Craniofacial Research (R01DE031729-01A1).

VR Score

91

Informative language

98

Neutral language

52

Article tone

formal

Language

English

Language complexity

70

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links